The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 8,029 | 311,217 | SH | DFND | 1,2 | 311,217 | 0 | 0 | |
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 3,983 | 502,900 | SH | DFND | 1,2 | 502,900 | 0 | 0 | |
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 26,082 | 375,870 | SH | DFND | 1,2 | 375,870 | 0 | 0 | |
BIOGEN INC | COM | 09062X103 | 20,981 | 75,000 | SH | DFND | 1,2 | 75,000 | 0 | 0 | |
COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 20,415 | 861,410 | SH | DFND | 1,2 | 861,410 | 0 | 0 | |
CONSTELLATION PHARMCETICLS I | COM | 210373106 | 20,406 | 872,415 | SH | DFND | 1,2 | 872,415 | 0 | 0 | |
EXELIXIS INC | COM | 30161Q104 | 27,133 | 1,201,100 | SH | DFND | 1,2 | 1,201,100 | 0 | 0 | |
GERON CORP | COM | 374163103 | 4,124 | 2,610,000 | SH | DFND | 1,2 | 2,610,000 | 0 | 0 | |
INFLARX NV | COM | N44821101 | 8,580 | 2,200,000 | SH | DFND | 1,2 | 2,200,000 | 0 | 0 | |
INSULET CORP | COM | 45784P101 | 23,378 | 89,600 | SH | DFND | 1,2 | 89,600 | 0 | 0 | |
INTERSECT ENT INC | COM | 46071F103 | 27,828 | 1,332,773 | SH | DFND | 1,2 | 1,332,773 | 0 | 0 | |
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 29,444 | 930,000 | SH | DFND | 1,2 | 930,000 | 0 | 0 | |
KADMON HLDGS INC | COM | 48283N106 | 18,497 | 4,755,000 | SH | DFND | 1,2 | 4,755,000 | 0 | 0 | |
LANTHEUS HLDGS INC | COM | 516544103 | 13,880 | 649,516 | SH | DFND | 1,2 | 649,516 | 0 | 0 | |
MACROGENICS INC | COM | 556099109 | 42,998 | 1,350,000 | SH | DFND | 1,2 | 1,350,000 | 0 | 0 | |
MIRATI THERAPEUTICS INC | COM | 60468T105 | 23,126 | 135,000 | SH | DFND | 1,2 | 135,000 | 0 | 0 | |
NEVRO CORP | COM | 64157F103 | 11,160 | 80,000 | SH | DFND | 1,2 | 80,000 | 0 | 0 | |
OCULAR THERAPEUTIX INC | COM | 67576A100 | 16,525 | 1,007,012 | SH | DFND | 1,2 | 1,007,012 | 0 | 0 | |
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 4,565 | 250,000 | SH | DFND | 1,2 | 250,000 | 0 | 0 | |
PULMONX CORP | COM | 745848101 | 5,230 | 114,345 | SH | DFND | 1,2 | 114,345 | 0 | 0 | |
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 12,636 | 1,300,000 | SH | DFND | 1,2 | 1,300,000 | 0 | 0 | |
REDHILL BIOPHARMA LTD | SPONSORED ADS | 757468103 | 5,163 | 705,305 | SH | DFND | 1,2 | 705,305 | 0 | 0 | |
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 33,721 | 760,000 | SH | DFND | 1,2 | 760,000 | 0 | 0 | |
SAGE THERAPEUTICS INC | COM | 78667J108 | 28,599 | 382,085 | SH | DFND | 1,2 | 382,085 | 0 | 0 | |
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 14,825 | 593,712 | SH | DFND | 1,2 | 593,712 | 0 | 0 | |
TRICIDA INC | COM | 89610F101 | 1,849 | 349,600 | SH | DFND | 1,2 | 349,600 | 0 | 0 | |
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 26,162 | 156,406 | SH | DFND | 1,2 | 156,406 | 0 | 0 | |
Y-MABS THERAPEUTICS INC | COM | 984241109 | 4,536 | 150,000 | SH | DFND | 1,2 | 150,000 | 0 | 0 |